Index -
P/E 38.58
EPS (ttm) 0.72
Insider Own 36.19%
Shs Outstand 124.10M
Perf Week -0.71%
Market Cap 5.14B
Forward P/E 26.06
EPS next Y 1.07
Insider Trans -0.04%
Shs Float 117.81M
Perf Month 17.97%
Income 147.58M
PEG 4.29
EPS next Q 0.22
Inst Own 56.25%
Short Float 9.73%
Perf Quarter -0.57%
Sales 475.42M
P/S 10.81
EPS this Y 3.09%
Inst Trans 3.52%
Short Ratio 6.88
Perf Half Y 13.50%
Book/sh 4.83
P/B 5.76
EPS next Y 9.03%
ROA 13.24%
Short Interest 11.46M
Perf Year -10.28%
Cash/sh 4.13
P/C 6.74
EPS next 5Y 9.00%
ROE 15.81%
52W Range 19.71 - 36.29
Perf YTD -0.75%
Dividend Est. -
P/FCF 27.93
EPS past 5Y 193.38%
ROI 16.15%
52W High -23.31%
Beta 1.22
Dividend TTM -
Quick Ratio 6.17
Sales past 5Y 43.01%
Gross Margin 89.34%
52W Low 41.20%
ATR (14) 1.02
Dividend Ex-Date -
Current Ratio 6.17
EPS Y/Y TTM 33.46%
Oper. Margin 36.34%
RSI (14) 63.46
Volatility 3.47% 3.31%
Employees 827
Debt/Eq 0.02
Sales Y/Y TTM 13.45%
Profit Margin 31.04%
Recom 2.68
Target Price 29.57
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 40.08%
Payout 0.00%
Rel Volume 0.63
Prev Close 27.41
Sales Surprise 1.42%
EPS Surprise 24.56%
Sales Q/Q 6.39%
Earnings May 16 AMC
Avg Volume 1.67M
Price 27.83
SMA20 11.44%
SMA50 8.28%
SMA200 10.45%
Trades
Volume 1,049,683
Change 1.53%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-25-24 Upgrade
JP Morgan
Underweight → Neutral
$25
Feb-26-24 Initiated
Leerink Partners
Market Perform
$32
Jan-03-24 Initiated
Barclays
Equal Weight
$31
Jan-02-24 Upgrade
BofA Securities
Underperform → Neutral
$21 → $29
Aug-09-23 Downgrade
Needham
Buy → Hold
Aug-09-23 Downgrade
Guggenheim
Buy → Neutral
Aug-03-23 Downgrade
Piper Sandler
Overweight → Neutral
$38 → $36
May-01-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$39 → $37
Jan-06-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$32 → $29
Oct-31-22 Initiated
Wells Fargo
Overweight
$38
Oct-24-22 Initiated
Evercore ISI
In-line
$28
Oct-13-22 Initiated
BTIG Research
Neutral
Sep-16-22 Initiated
KeyBanc Capital Markets
Sector Weight
Sep-07-22 Initiated
Truist
Hold
$35
Aug-05-22 Downgrade
BofA Securities
Neutral → Underperform
$43 → $29
Jul-28-22 Initiated
Berenberg
Buy
$49
May-18-22 Reiterated
Needham
Buy
$70 → $45
May-18-22 Reiterated
Morgan Stanley
Equal-Weight
$55 → $35
May-18-22 Reiterated
Jefferies
Buy
$78 → $46
May-18-22 Reiterated
Guggenheim
Buy
$70 → $52
Show Previous Ratings
May-23-24 09:01AM
09:00AM
May-17-24 05:15PM
02:13PM
12:01PM
11:46AM
Loading…
11:46AM
11:15AM
11:13AM
10:56AM
10:35AM
10:02AM
(The Wall Street Journal)
09:21AM
(Thomson Reuters StreetEvents)
08:50AM
08:10AM
05:26AM
08:53PM
Loading…
May-16-24 08:53PM
05:10PM
04:30PM
04:17PM
(Associated Press Finance)
04:08PM
04:01PM
May-15-24 03:01AM
May-14-24 06:15AM
May-13-24 09:15AM
Apr-25-24 04:01PM
11:34AM
Apr-03-24 09:35AM
Mar-28-24 12:00PM
Mar-19-24 06:39AM
06:14AM
05:15AM
Loading…
Feb-23-24 05:15AM
Feb-22-24 04:01PM
Feb-21-24 08:30AM
06:15AM
Feb-09-24 10:28AM
07:25AM
(Thomson Reuters StreetEvents)
Feb-08-24 07:00PM
05:10PM
04:50PM
04:11PM
04:10PM
(Associated Press Finance)
04:05PM
04:01PM
Feb-07-24 02:02AM
Feb-06-24 09:15AM
Jan-22-24 03:57AM
Jan-18-24 04:01PM
Jan-17-24 02:21AM
Jan-16-24 02:29AM
Jan-11-24 04:20AM
Jan-09-24 04:59AM
Jan-08-24 04:22PM
Dec-29-23 12:00PM
07:00AM
Dec-21-23 10:07AM
Dec-10-23 12:03PM
Dec-06-23 08:58AM
Dec-02-23 08:10AM
Nov-26-23 11:53AM
Nov-24-23 12:20PM
Nov-14-23 04:53PM
Nov-11-23 11:56AM
Nov-10-23 04:40PM
01:01PM
12:18PM
(Associated Press Finance)
12:01PM
09:49AM
Nov-09-23 07:00PM
04:20PM
(Associated Press Finance)
04:15PM
04:01PM
Nov-08-23 02:03AM
Nov-06-23 09:57PM
Nov-02-23 10:00AM
Nov-01-23 09:05AM
Oct-31-23 04:54AM
Oct-28-23 09:15AM
Oct-27-23 09:45AM
Oct-19-23 04:05PM
Oct-12-23 06:39AM
Oct-07-23 06:00AM
Oct-06-23 12:27PM
Oct-03-23 11:40AM
Sep-25-23 07:15AM
Sep-24-23 05:47AM
Sep-06-23 08:40AM
Aug-24-23 08:30AM
Aug-16-23 10:15AM
Aug-14-23 05:32AM
Aug-12-23 10:07AM
Aug-11-23 11:09PM
Aug-09-23 04:22PM
01:19PM
12:21PM
11:31AM
(Thomson Reuters StreetEvents)
10:26AM
09:40AM
Aug-08-23 06:30PM
05:30PM
04:26PM
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wampler Kira Scherer Director May 17 '24 Sale 27.22 2,500 68,050 10,258 May 17 05:35 PM Overpeck Craig See Remarks May 16 '24 Sale 23.85 1,500 35,775 108,609 May 17 05:34 PM Wampler Kira Scherer Director Apr 01 '24 Sale 26.97 2,500 67,425 10,258 Apr 02 04:09 PM Wampler Kira Scherer Director Mar 01 '24 Sale 27.88 2,500 69,700 10,258 Mar 04 04:03 PM Overpeck Craig See Remarks Feb 16 '24 Sale 30.02 1,500 45,030 112,971 Feb 16 04:11 PM Wampler Kira Scherer Director Feb 01 '24 Sale 27.05 2,500 67,625 10,258 Feb 02 04:03 PM Wampler Kira Scherer Director Jan 02 '24 Sale 28.27 5,000 141,330 10,258 Jan 03 04:26 PM Wampler Kira Scherer Director Dec 15 '23 Sale 26.65 2,500 66,625 10,258 Dec 18 04:12 PM Wampler Kira Scherer Director Dec 14 '23 Sale 26.00 2,500 65,000 10,258 Dec 18 04:12 PM Wampler Kira Scherer Director Nov 24 '23 Sale 24.41 2,500 61,025 10,258 Nov 28 04:06 PM Overpeck Craig See Remarks Nov 16 '23 Sale 25.23 1,500 37,845 116,470 Nov 17 04:04 PM Overpeck Craig See Remarks Oct 16 '23 Sale 21.55 1,000 21,550 119,741 Oct 18 04:06 PM Overpeck Craig See Remarks Sep 15 '23 Sale 21.48 1,000 21,480 120,741 Sep 19 04:08 PM Cabral Timothy S Director Jul 28 '23 Sale 34.96 4,714 164,787 10,258 Jul 31 04:28 PM Cabral Timothy S Director Jul 12 '23 Sale 35.00 7,500 262,500 4,714 Jul 13 04:03 PM Cabral Timothy S Director Jul 03 '23 Sale 33.80 10,000 338,050 4,714 Jul 06 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite